Cochlear Ltd (ASX:COH)
A$ 111.61 -0.50 (-0.45%) Market Cap: 7.30 Bil Enterprise Value: 7.35 Bil PE Ratio: 21.16 PB Ratio: 3.77 GF Score: 67/100

Half Year 2020 Cochlear Ltd Earnings Presentation Transcript

Feb 18, 2020 / NTS GMT
Release Date Price: A$226.62 (-3.39%)

Feb 18, 2020 / NTS GMT
Presentation
Feb 18, 2020 / NTS GMT

=====================
Corporate Participants
=====================
* Brent Andrew Cubis
Cochlear Limited - CFO
* Diggory William Howitt
Cochlear Limited - CEO, MD, President & Executive Director

=====================
Conference Call Participants
=====================
* Andrew Goodsall
MST Marquee - Healthcare analyst
* Chris Cooper
Goldman Sachs Group Inc., Research Division - Research Analyst
* David A. Low
JP Morgan Chase & Co, Research Division - Research Analyst
* David Andrew Stanton
Jefferies LLC, Research Division - Equity Analyst
* David Bailey
Macquarie Research - Research Analyst
* Gretel Janu
Crédit Suisse AG, Research Division - Research Analyst
* Hashan De Silva
CLSA Limited, Research Division - Research Analyst
* John Deakin-Bell
Citigroup Inc, Research Division - Director & Head of Healthcare in Australia and New Zealand
* Lyanne Harrison
BofA Merrill

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot